Beyond ASX shares: Bell Asset tips three international shares as buys

International share markets offer some compelling investment opportunities.

Best asx small cap stock global opportunity

Image source: Getty Images

There are plenty of quality, high performing ASX shares.

Like online luxury goods retailer Cettire Ltd (ASX: CTT). The Cettire share price tops the leader’s board of big gainers on the All Ordinaries Index (ASX: XAO) in 2021, up a remarkable 618% year-to-date.

With that said, ASX shares make up only some 2% of the total global share market. So it’s worth considering looking beyond our shores to potential opportunities overseas.

But don’t just take my word for it.

According to The Motley Fool’s own Scott Phillips:

Investing internationally delivers tremendous portfolio diversification benefits and brings a world of opportunities to your investment doorstep.

And indeed, while the diversification benefits are very important, I actually think they run second to the sheer investment opportunities that exist overseas. Some of the very best companies on this blue and green planet aren’t on the ASX – so why would we limit ourselves to just our home market?

With that in mind, we take a look at 3 small-cap international shares tipped during yesterday’s ‘Bell Asset Management – Global equities market update and outlook for 2022’ webinar.

Looking beyond ASX shares

Ned Bell, Bell Asset Management’s chief investment officer, spearheaded the webinar.

On the buy side for the asset manager, he named 3 international shares that have come off their highs to be trading within Bell Asset’s buy level. Namely: Amedisys Inc (NASDAQ: AMED), GN Store Nord A/S (CPH: GN) and Intertek Group plc (LON: ITRK).

According to Bell:

GN, Intertek and Amedisys… are 3 names that we’ve been watching. We’ve owned Intertek before… They’ve been a little bit too expensive. We’ve been waiting from some earnings uncertainty and volatility to give us a buying opportunity. And that’s exactly what’s happened.

Those 3 names have come off their highs. They’ve got down to our buy levels, and that’s what triggered the buy here…

What these stocks all have in common, Bell added, “is that we’ve been patient on getting into them. And we think, looking ahead to the next 12-24 months, you’re going to get some P/E [price to earnings ratio] re-ratings.”

If you’ve been focused primarily on ASX shares you may not be familiar with these names.

In a nutshell:

Amedisys is a US healthcare company with a market cap of approximately US$5.4 billion. Shares finished up 4% yesterday but remain down 40% over the past 6 months.

GN is a Danish manufacturer of hearing aids and headsets. The GN share price finished up 1% yesterday and is down 24% over the past 6 months.

Intertek is a London-based global quality assurance provider. Shares finished flat yesterday and are down 20% over the past 6 months.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Cettire Limited. The Motley Fool Australia has recommended Cettire Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on International Stock News